Figure 6.
Loss of epithelial barrier–forming ability in anti-KLF4 siRNA treated cells. TEER developed by wild-type, control siRNA, or anti-KLF4 siRNA–treated HCE cells cultured on permeable supports (Transwell plates; Corning Costar) was estimated every day for 15 days, as a measure of epithelial barrier–forming ability.